TRULIEVE CANNABIS CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.68 CAD | -5.19% |
|
-1.02% | +70.51% |
| Sales 2024 * | 1.19B 1.63B | Sales 2025 * | 1.25B 1.71B | Capitalization | 1.68B 2.3B |
|---|---|---|---|---|---|
| Net income 2024 * | -79M -108M | Net income 2025 * | -26M -35.7M | EV / Sales 2024 * | 1.55 x |
| Net Debt 2024 * | 156M 215M | Net cash position 2025 * | 145M 199M | EV / Sales 2025 * | 1.23 x |
| P/E ratio 2024 * |
-19.9
x | P/E ratio 2025 * |
-58.1
x | Employees | 5,400 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.92% |
More Fundamentals
* Assessed data
More news
Latest transcript on Trulieve Cannabis Corp.
More recommendations
More press releases
More news
| 1 day | -5.19% | ||
| 1 week | -1.02% | ||
| Current month | -12.31% | ||
| 1 month | -28.56% | ||
| 3 months | -10.08% | ||
| 6 months | +64.51% | ||
| Current year | +70.51% |
1 week
11.66
13.49
1 month
11.6418.39
Current year
6.7120.00
1 year
4.6620.00
3 years
4.6649.49
5 years
4.6667.45
10 years
4.6667.45
| Managers | Title | Age | Since |
|---|---|---|---|
Kimberly Rivers
CEO | Chief Executive Officer | - | 40-09-16 |
Ryan Blust
DFI | Director of Finance/CFO | - | 18-08-31 |
Nilyum Jhala
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jane Morreau
BRD | Director/Board Member | 65 | 21-06-09 |
Thomas Millner
BRD | Director/Board Member | 70 | 20-06-01 |
Peter Healy
BRD | Director/Board Member | 72 | 19-07-14 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 28 M€ | -0.97% | - | |
| 0.00% | 145 M€ | -1.13% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-14 | 11.68 | -5.19% | 141,457 |
| 24-06-13 | 12.32 | -6.17% | 106,887 |
| 24-06-12 | 13.13 | -0.53% | 53,873 |
| 24-06-11 | 13.2 | +0.30% | 69,299 |
| 24-06-10 | 13.16 | +4.44% | 137,680 |
Delayed Quote Canadian Securities Exchange, June 14, 2024 at 03:59 pm EDT
More quotes
Trulieve Cannabis Corp. is a vertically integrated cannabis company. The Company has established cannabis operations in three hubs: Southeast, Northeast, and Southwest. Its three regional hubs are anchored by market positions in cornerstone states of Florida, Pennsylvania, and Arizona. The Company operates in regulated markets that require knowledge in cultivation, manufacturing, and retail. The Company utilizes various extraction techniques, including critical ethanol extraction, carbon dioxide extraction, hydrocarbon extraction, and mechanical separation. In addition, the Company owns and utilizes carbon dioxide extraction, distillation, purification and manufacturing technology that is used to produce a range of cannabis topicals and vapes featuring cannabinoids. The Company's brands include premium tier brands Avenue, Cultivar Collection, and Muse; mid-tier brands Modern Flower, Alchemy, Momenta, and Sweet Talk, and value tier brands Co2lors, Loveli, Roll One, and Trekkers.
Sector
Pharmaceuticals
Calendar
2024-08-06
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
8.959
USD
Average target price
18.67
USD
Spread / Average Target
+108.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +70.51% | 1.68B | |
| -0.18% | 3.14B | |
| +106.35% | 71.97M |
- Stock Market
- Equities
- TRUL Stock
